Travere Therapeutics Inc (TVTX)
followers
·
Follow
Sector:
MATERIALS
Industry:
CHEMICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Eric M. Dube
Employees:
460
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
888-969-7879
-
Formally known as:
- DESERT GATEWAY INC
- DESERT GATEWAY, INC.
- DESERT GATEWAY, INC. COMMON STOCK
- DESERT GATEWAY, INC. COMMON STOCK
Travere Therapeutics, Inc. focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid. The company's product candidates also consist of Sparsentan, which is in Phase III clinical trial for the. treatment of focal segmental glomerulosclerosis and immunoglobulin A nephropathy.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|